Carcinogenesis, Vol. 23, No. 7, 1095-1102,
July 2002
© 2002 Oxford University Press
COMMENTARY |
The initiation of breast and prostate cancer
1 Institute of Cancer Research, Haddow Laboratories, Cotswold Road, Sutton, Surrey SM2 5NG, UK and
2 Department of Biological Sciences, Institute of Environmental and Natural Sciences, Lancaster University, Lancaster LA1 4YQ, UK
The agents responsible for the initiation of human mammary and prostatic cancers remain unidentified. Population migration studies on breast and prostate cancer risk have revealed that incidence rates in migrants from low-risk to high-risk ‘Westernized’ countries rise over time to match those of the host populations. The parallels suggest that the two diseases may share a common aetiology, with changes in diet, rather than in environment, being responsible for the migration-related increases in cancer incidence. Genotoxins, such as polycyclic aromatic hydrocarbons and heterocyclic aromatic amines, are formed when foodstuffs are cooked at elevated temperatures and can be extracted with solvents: other genotoxins may only be released from cooked proteins when digestion occurs in the gastrointestinal tract. Human mammary and prostatic epithelial cells are known to be capable of metabolically activating members of different classes of chemical carcinogens to DNA-reactive species and, in rodents, five out of six mammary carcinogens can also induce prostatic neoplasms. Genotoxins have been detected in some 40% of breast lipid and milk samples donated by UK-resident women but the agents, currently thought to be of dietary origin, have not been characterized or identified as yet. Reduction mammoplasty and lactation both reduce breast cancer risk and the reduction is proportional either to the amount of tissue removed or to the total duration of lactation. As DNA damage has been detected in otherwise untreated mammary epithelial cells isolated both from breast tissue and from breast milk, we have proposed that reduction mammoplasty and lactation reduce risk through a common mechanism, i.e. the loss of pre-malignant cells. Further research, perhaps aimed particularly at the characterization of all the carcinogens formed when different dietary components are cooked in different ways, should succeed in identifying the agents that initiate breast and prostate cancer.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  O. V. Martin, J. N. Lester, N. Voulvoulis, and A. R. Boobis Human Health and Endocrine Disruption: A Simple Multicriteria Framework for the Qualitative Assessment of End Point Specific Risks in a Context of Scientific Uncertainty Toxicol. Sci., August 1, 2007; 98(2): 332 - 347. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Jiao, S. L. Allinson, M. J. Walsh, R. Hewitt, K. J. Cole, D. H. Phillips, and F. L. Martin Growth kinetics in MCF-7 cells modulate benzo[a]pyrene-induced CYP1A1 up-regulation Mutagenesis, March 1, 2007; 22(2): 111 - 116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Barber, M. J. Walsh, R. Hewitt, K. C. Jones, and F. L. Martin Low-dose treatment with polybrominated diphenyl ethers (PBDEs) induce altered characteristics in MCF-7 cells Mutagenesis, September 1, 2006; 21(5): 351 - 360. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. German, A. Hammiche, N. Ragavan, M. J. Tobin, L. J. Cooper, S. S. Matanhelia, A. C. Hindley, C. M. Nicholson, N. J. Fullwood, H. M. Pollock, et al. Infrared Spectroscopy with Multivariate Analysis Potentially Facilitates the Segregation of Different Types of Prostate Cell Biophys. J., May 15, 2006; 90(10): 3783 - 3795. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-I. Huh, A. Calvo, R. Charles, and J. E. Green Distinct tumor stage-specific inhibitory effects of 2-methoxyestradiol in a breast cancer mouse model associated with id-1 expression. Cancer Res., April 1, 2006; 66(7): 3495 - 3503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. L. Martin and K. T. Semple Environmental health impacts: occurrence, exposure and significance, Lancaster University, UK, 9-10 September 2003 Mutagenesis, September 1, 2004; 19(5): 423 - 429. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. I. Kalantzi, R. Hewitt, K. J. Ford, L. Cooper, R. E. Alcock, G. O. Thomas, J. A. Morris, T. J. McMillan, K. C. Jones, and F. L. Martin Low dose induction of micronuclei by lindane Carcinogenesis, April 1, 2004; 25(4): 613 - 622. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Nowell, D. L. Ratnasinghe, C. B. Ambrosone, S. Williams, T. Teague-Ross, L. Trimble, G. Runnels, A. Carrol, B. Green, A. Stone, et al. Association of SULT1A1 Phenotype and Genotype with Prostate Cancer Risk in African-Americans and Caucasians Cancer Epidemiol. Biomarkers Prev., February 1, 2004; 13(2): 270 - 276. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Fulop Integrative Tumor Board: Recurrent Breast Cancer or New Primary? Integr Cancer Ther, September 1, 2003; 2(3): 276 - 283. [PDF]
|
|